How to Get Oral Micronized Progesterone in District of Columbia

Why Oral Micronized Progesterone Matters for HRT in DC

Oral micronized progesterone is the only bioidentical progesterone with full FDA approval for endometrial protection during estrogen-based hormone replacement therapy. The distinction matters clinically. In the PEPI Trial (N=875), women randomized to oral micronized progesterone 200 mg for 12 days per cycle experienced significantly less endometrial hyperplasia than those on placebo while preserving the HDL cholesterol benefits of estrogen therapy 1. Synthetic progestins in the same trial blunted those lipid gains.

Washington, DC, has a regulatory environment that favors patient access. The District grants nurse practitioners full practice authority under DC Code § 3-1206.04, meaning NPs can independently evaluate, diagnose, and prescribe progesterone without physician oversight. This expands the prescriber pool considerably for residents seeking hormone therapy. DC also permits telehealth prescribing for scheduled medications when a valid provider-patient relationship is established through synchronous audio-video consultation, per DC Health regulations updated in 2024.

For women on estrogen who still have a uterus, adding progesterone is not optional. The Endocrine Society's 2015 clinical practice guideline states: "We recommend that all postmenopausal women with a uterus who are treated with systemic estrogen therapy also receive progestogen therapy to prevent endometrial hyperplasia and cancer." That recommendation carries a Grade 1A evidence rating.

Step-by-Step: Getting a Prescription in DC

The process from initial consultation to filled prescription typically takes 3 to 10 business days, depending on the prescribing pathway and insurance requirements. Here is how each step works.

1. Choose a prescriber. You can see an OB-GYN, endocrinologist, internist, family medicine physician, nurse practitioner, or physician assistant. All of these provider types hold prescriptive authority for progesterone in the District.

2. Complete an evaluation. The prescriber will review your symptoms, menstrual history (if applicable), surgical history, and current medications. Expect questions about breast cancer risk, history of venous thromboembolism, and liver function, because these affect progesterone eligibility per the FDA-approved prescribing information.

3. Obtain baseline labs. Most DC prescribers order a basic panel before initiating progesterone as part of HRT. Common tests include a comprehensive metabolic panel (CMP) covering liver enzymes (AST, ALT), a lipid panel, serum estradiol, FSH, and TSH. A recent mammogram within 12 months is standard for postmenopausal patients. Some providers also check a baseline endometrial thickness via transvaginal ultrasound if the patient reports any irregular bleeding.

4. Receive the prescription. Once labs are reviewed and eligibility confirmed, the prescriber sends the Rx electronically to your chosen pharmacy. Standard prescriptions read either 200 mg nightly (continuous regimen) or 200 mg for 12 days per calendar month (cyclic regimen). The continuous regimen is more common for women who are more than 12 months past their final menstrual period.

5. Fill at a pharmacy. Brand-name Prometrium and generic micronized progesterone capsules (manufactured by Teva, Mylan, and others) are stocked at most retail chains in DC, including CVS, Walgreens, and Rite Aid locations. If your provider prescribes a custom dose or formulation, a 503A compounding pharmacy can prepare it.

Telehealth Access for DC Residents

DC residents can legally obtain an oral micronized progesterone prescription through telehealth, and several platforms now specialize in hormone therapy consultations. A valid telehealth visit in the District requires a live, synchronous video or audio-video encounter. Asynchronous questionnaire-only platforms do not satisfy DC's prescribing standards for new prescriptions of hormone therapy.

The telehealth workflow is straightforward. You schedule a consultation, upload or complete labs at a local draw site (Quest Diagnostics and Labcorp both operate multiple locations in DC), and then meet with a licensed provider via video. If the clinician determines that progesterone is appropriate, the prescription is sent electronically to your pharmacy that same day. Most patients report receiving their medication within 3 to 5 business days of their telehealth appointment when using a retail pharmacy with stock on hand.

One advantage of telehealth for DC residents is access to providers who specialize in menopause and hormone therapy. According to the North American Menopause Society's 2022 position statement, only about 20% of OB-GYN residency programs provide dedicated menopause training, which means finding a knowledgeable local prescriber can be difficult. Telehealth platforms that focus on HRT often employ clinicians with NAMS certification (Certified Menopause Practitioner designation), which signals focused training in hormone management.

DC does not require an in-person visit before a telehealth provider can prescribe progesterone, as long as the standard of care is met during the virtual encounter. This is a significant access advantage compared to some states that mandate an initial in-person visit for controlled or hormonal medications.

DC Medicaid Coverage and Prior Authorization

DC Medicaid (administered through Medicaid managed care organizations including AmeriHealth Caritas DC and CareFirst Community Health Plan) covers oral micronized progesterone for the indication of endometrial protection during HRT. Coverage requires prior authorization (PA).

The PA process involves your prescriber submitting documentation to the managed care plan. Required documentation typically includes:

• A confirmed diagnosis of menopause or postmenopausal status (ICD-10 codes E28.310, N95.1, or Z78.0 are commonly used)
• Evidence that the patient has an intact uterus
• Confirmation that the patient is concurrently prescribed systemic estrogen therapy
• Relevant lab results (FSH, estradiol) supporting the diagnosis
• A statement of medical necessity explaining why progesterone is required for endometrial protection

PA turnaround in DC Medicaid plans generally runs 24 to 72 hours for standard requests. Urgent requests, which apply when a patient has already started estrogen and needs progesterone added promptly, may be processed within 24 hours. If the initial PA is denied, DC Medicaid beneficiaries have the right to appeal through the managed care organization and, if needed, request a fair hearing through the DC Department of Health Care Finance.

The average retail cash price for a 30-day supply of generic oral micronized progesterone 200 mg in DC ranges from $25 to $60 without insurance, based on GoodRx pricing data for 20008 and 20009 ZIP codes. Brand-name Prometrium is significantly more expensive, typically $250 to $350 for 30 capsules at retail without a discount card. For most patients, the generic is therapeutically equivalent and preferred by insurers.

503A Compounding Pharmacies in DC

Licensed 503A compounding pharmacies in the District of Columbia can prepare oral micronized progesterone in custom doses or formulations when a prescriber determines that a commercially available product does not meet a patient's clinical needs. This might apply when a patient needs a dose between the standard 100 mg and 200 mg options, requires a peanut-oil-free formulation (Prometrium's capsule base contains peanut oil), or needs progesterone combined with another hormone in a single preparation.

Under federal law (Drug Quality and Security Act, Section 503A), these pharmacies compound medications based on individual patient prescriptions. They are licensed by the DC Board of Pharmacy and must comply with USP <795> standards for non-sterile compounding. DC does not prohibit 503A pharmacies from shipping compounded prescriptions to patients within the District, though interstate shipping rules are governed by the receiving state's laws.

A few points of caution. The FDA's 2020 guidance on compounded bioidentical hormones notes that compounded products are not FDA-approved, do not undergo the same rigorous testing for potency and consistency as manufactured drugs, and should only be used when a patient has a documented medical need that cannot be met by an FDA-approved product. If standard Prometrium or its generics work for you, that is the preferred clinical path.

Who Can Prescribe: MD vs. NP vs. PA in DC

All three provider types can prescribe oral micronized progesterone in the District. Here are the specific scopes.

Physicians (MDs and DOs) have unrestricted prescriptive authority for progesterone. Any physician licensed in DC through the DC Board of Medicine can prescribe, regardless of specialty, though OB-GYNs, endocrinologists, and primary care physicians are the most common prescribers for HRT.

Nurse Practitioners in DC hold full practice authority under the District of Columbia Health Occupations Revision Act. Since 2020, DC NPs have been able to prescribe, diagnose, and treat independently without a collaborative practice agreement with a physician. This makes DC one of the more permissive jurisdictions for NP-led hormone therapy management.

Physician Assistants may prescribe progesterone in DC under their supervising physician's delegated authority. The supervision can be remote (the physician does not need to be physically present), but a supervisory relationship must be documented.

For telehealth encounters specifically, the prescribing provider must hold a DC license or be authorized to practice in the District through an interstate compact or temporary telehealth registration. The Interstate Medical Licensure Compact includes DC, which means physicians licensed through the compact can provide telehealth services to DC residents without obtaining a separate DC license.

What to Expect After Starting Progesterone

Once you begin oral micronized progesterone, your prescriber will typically schedule a follow-up in 4 to 8 weeks. That visit (in-person or telehealth) assesses symptom response, side effects, and determines whether the dosing regimen needs adjustment.

Common side effects include drowsiness (reported in 24% of participants in the PEPI Trial 1), dizziness, and breast tenderness. Taking the capsule at bedtime minimizes the sedation effect and may actually improve sleep quality. A 2019 systematic review in the Journal of Clinical Endocrinology & Metabolism found that oral micronized progesterone was associated with improved subjective sleep quality in postmenopausal women, likely related to its conversion to the neurosteroid allopregnanolone, which acts on GABA-A receptors.

Breakthrough bleeding can occur during the first 3 to 6 months, especially on continuous regimens. The American College of Obstetricians and Gynecologists Practice Bulletin No. 141 recommends endometrial evaluation (typically transvaginal ultrasound) for any unscheduled bleeding that persists beyond 6 months of continuous combined HRT, or for any bleeding that occurs after a period of amenorrhea on therapy.

Lab monitoring at 3 to 6 months post-initiation usually includes a repeat lipid panel and liver function tests. The prescriber may also check serum progesterone levels, though trough levels of oral micronized progesterone are notoriously variable due to first-pass hepatic metabolism and are not routinely used to guide dosing. Clinical response (endometrial protection confirmed by absence of hyperplasia, resolution of symptoms) is the primary measure of therapeutic success.

Transferring a Prescription to DC

If you are relocating to Washington, DC, from another state and already have an active progesterone prescription, the transfer process depends on your pharmacy chain. National chains like CVS and Walgreens can transfer prescriptions between locations in different states, provided the prescription is valid (not expired, has remaining refills). Your DC pharmacist will verify that the prescription was written by a provider licensed in a US jurisdiction and that it complies with DC pharmacy regulations.

For compounded prescriptions, transfer is more complex. A 503A prescription written for a patient in another state may need to be reissued by a provider licensed in DC or by a provider whose license is recognized in DC. This is because compounding prescriptions are patient-specific and often tied to the prescriber-pharmacy relationship.

If your out-of-state prescription has no remaining refills or is close to expiration, establishing care with a new DC-based provider (or a telehealth platform licensed in DC) is the most efficient path. Many telehealth platforms can schedule new patient consultations within 48 to 72 hours and accept lab results from within the prior 6 months, so you may not need to repeat bloodwork.

Patients moving from states with more restrictive telehealth or NP prescribing laws may find that DC's regulatory framework provides broader access than they previously had.